CoChat

Idiopathic pulmonary fibrosis

The DOI matches its Crossref record; 145 of the 147 references it cites were found in a registry or an index.

Abstract

Idiopathic pulmonary fibrosis is a devastating, age-related lung disease of unknown cause that has few treatment options. This disease was once thought to be a chronic inflammatory process, but current evidence indicates that the fibrotic response is driven by abnormally activated alveolar epithelial cells (AECs). These cells produce mediators that induce the formation of fibroblast and myofibroblast foci through the proliferation of resident mesenchymal cells, attraction of circulating fibrocytes, and stimulation of the epithelial to mesenchymal transition. The fibroblast and myofibroblast foci secrete excessive amounts of extracellular matrix, mainly collagens, resulting in scarring and destruction of the lung architecture. The mechanisms that link idiopathic pulmonary fibrosis with ageing and aberrant epithelial activation are unknown; evidence suggests that the abnormal recapitulation of developmental pathways and epigenetic changes have a role. In this Seminar, we review recent data on the clinical course, therapeutic options, and underlying mechanisms thought to be involved in the pathogenesis of idiopathic pulmonary fibrosis.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(11)60052-4

Cites

145 of 145 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 145 references

Cited by

See all 2,194

Metadata

Authors
King, T. E., Pardo, A., & Selman, M.
Affiliations
  • University of California, San Francisco (US)
  • Universidad Nacional Autónoma de México (MX)
  • Instituto Nacional de Enfermedades Respiratorias (MX)
Corresponding author
King, Talmadge E
Venue
The Lancet
Publisher
Elsevier BV
Published
2011-12
Volume
378
Issue
9807
Pages
1949-1961
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W1993559550
Cited by
2,194
References
147
Citations by year
2026: 110 · 2025: 132 · 2024: 163 · 2023: 143 · 2022: 164 · 2021: 180 · 2020: 148 · 2019: 137 · 2018: 162 · 2017: 160 · 2016: 125 · 2015: 155 · 2014: 132 · 2013: 123 · 2012: 83
FWCI
18.80
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
Keywords
idiopathic pulmonary fibrosis, alveolar epithelial cells, fibroblast foci, myofibroblasts, fibrocytes, epithelial-mesenchymal transition, extracellular matrix, collagen deposition, lung scarring, aging, epigenetic modifications, pathogenesis, clinical course, treatment options
MeSH terms
Humans, Prognosis, Idiopathic Pulmonary Fibrosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Idiopathic pulmonary fibrosis. https://app.cochat.ai/papers/10.1016/s0140-6736(11)60052-4
The paper
King, T. E., Pardo, A., & Selman, M. (2011). Idiopathic pulmonary fibrosis. The Lancet. https://doi.org/10.1016/s0140-6736(11)60052-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.